Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) Sees Large Increase in Short Interest

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) was the recipient of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 731,000 shares, an increase of 15.7% from the January 15th total of 631,800 shares. Based on an average trading volume of 1,930,000 shares, the days-to-cover ratio is presently 0.4 days.

Petros Pharmaceuticals Stock Performance

Shares of PTPI stock traded up $0.05 during trading hours on Friday, hitting $0.29. The company had a trading volume of 107,200,541 shares, compared to its average volume of 383,633. Petros Pharmaceuticals has a fifty-two week low of $0.22 and a fifty-two week high of $1.76. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.74 and a current ratio of 0.85. The company’s fifty day moving average is $0.32 and its 200 day moving average is $0.33.

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc, a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).